Ai-driven Drug Discovery

Alt. Club, in partnership with Goodwin and L.E.K. Consulting, is inviting LP investors to join us for a special event in London, and meet high-profile industry experts, entrepreneurs and GP fund managers shaping the future of drug discovery. Our goal is to discuss the latest trends shaping the industry and learn from each other- especially from other LP investors.

Evening Event (6-7 pm)

• Keynote: 'The State of AI in BioPharma R&D' by Dr. Stephen Roper and Andre Valente (Partners, Healthcare & Life Sciences at L.E.K. Consulting)

• Panel discussion: 'AI-driven drug discovery: Unlocking the potential' with Dr. Rana Lonnen (Managing Director, Novartis dRx Capital), Dr Niven Narain (President & CEO, BPGbio and Advisory Board Member at The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School), Dr. Andreas Bender (Group leader for Data-Driven Drug Discovery at the Centre for Molecular Informatics, Department of Chemistry, Cambridge University). Moderated by Dr. Stephen Roper.

Afternoon Event (4.30-5.30 pm)

• CEO/Founders presenting: 

• Dr. Sam Windsor (CEO at Ignota Labs ) 

• Dr Steve Gardner (CEO at  PrecisionLife)

• Yann Gaston-Mathe (Founder & CEO, Iktos)

• Gavin Nichols (CEO, Stealth mode company)

• Jamie Cartland (CEO / Co-Founder at Conduit Bio)